Alpha heavy chain disease in Tunisia in 1981
Gargouri, M.; Amor, N.B.
Medecine and Chirurgie Digestives 11(3): 163-167
1982
ISSN/ISBN: 0047-6412 PMID: 6808260 Document Number: 196684
Document emailed within 1 workday
Related Documents
Lorie, N.Iu.; Ekisenina, N.I. 1981: Heavy alpha-chain disease Klinicheskaia Meditsina 59(4): 32-35Geraci, L.; Merlini, G.; Spadano, A.; Di Matteo, S.; Torlontano, G.; Ascari, E. 1985: Alpha heavy chain disease: report of two cases Haematologica 70(5): 431-436
Warnatz, H. 1974: Alpha-heavy chain disease a new clinical picture Fortschritte der Medizin 92(7): 290-293
Bouguerra, A.; Fennira, F. 1984: Alpha heavy chain disease and the hepatitis B virus Gastroenterologie Clinique et Biologique 8(4): 386-387
Tezuka, T.; Hirai, R.; Takahashi, M.; Furuta, I.; Ohba, Y.; Tsubaki, K.; Horiuchi, A. 1986: Alpha-heavy-chain disease with erythematous skin lesions Archives of Dermatology 122(11): 1243-1244
Ayed, K.; Makni, S.; Boujnah, A. 1980: Low molecular weight (7S) IgM in the sera of patients with the alpha heavy chain disease (HCD) La Nouvelle Presse Medicale 9(30): 2082-2083
Hubmann, R.; Kaiser, W.; Radaszkiewicz, T.; Fridrik, M.; Zazgornik, I. 1995: Malabsorption associated with a high-grade-malignant non-Hodgkin's lymphoma, alpha-heavy-chain disease and immunoproliferative small intestinal disease Zeitschrift für Gastroenterologie 33(4): 209-213
Doe, W.F.; Spiegelberg, H.L. 1979: Characterization of an antiserum specific for the Fabalpha fragment. Its use for detection of alpha-heavy chain disease protein by immunoselection Journal of Immunology 122(1): 19-23
Brodsky, I.G.; Suzara, D.; Hornberger, T.A.; Goldspink, P.; Yarasheski, K.E.; Smith, S.; Kukowski, J.; Esser, K.; Bedno, S. 2004: Isoenergetic dietary protein restriction decreases myosin heavy chain IIx fraction and myosin heavy chain production in humans Journal of Nutrition 134(2): 328-334
Buxbaum, J.N.; Chuba, J.V.; Hellman, G.C.; Solomon, A.; Gallo, G.R. 1990: Monoclonal immunoglobulin deposition disease: light chain and light and heavy chain deposition diseases and their relation to light chain amyloidosis. Clinical features, immunopathology, and molecular analysis Annals of Internal Medicine 112(6): 455-464
Meurs, E.; Hovanessian, A.G. 1988: Alpha-interferon inhibits the expression of heavy chain mu messenger RNA in Daudi cells EMBO Journal 7(6): 1689-1696
Dean, M.; Kent, R.B.; Sonenshein, G.E. 1983: Transcriptional activation of immunoglobulin alpha heavy-chain genes by translocation of the c-myc oncogene Nature 305(5933): 443-446
Langlands, K.; Craig, J.I.; Anthony, R.S.; Parker, A.C. 1993: Clonal selection in acute lymphoblastic leukaemia demonstrated by polymerase chain reaction analysis of immunoglobulin heavy chain and T-cell receptor delta chain rearrangements Leukemia 7(7): 1066-1070
Iavorkovskiĭ, L.I.; Pushkarev, I.A.; Guseva, L.N.; Magalif, N.I.; Apine, R.I. 1978: Case of heavy gamma chain disease Problemy Gematologii i Perelivaniia Krovi 23(12): 33-39
Lebreton, J.P.; Ropartz, C.; Biserte, G. 1974: Partial study of a case of heavy mu chain disease Lille Medical: Journal de la Faculte de Medecine et de Pharmacie de l'Universite de Lille 19(2): 126-131
Cooper, D.L.; Bolognia, J.L.; Lin, J.T. 1991: Atrophie blanche in a patient with gamma-heavy-chain disease Archives of Dermatology 127(2): 272-273
Sun, T.; Peng, S.; Narurkar, L. 1994: Modified immunoselection technique for definitive diagnosis of heavy-chain disease Clinical Chemistry 40(4): 664
Satirapoj, B.; Paueksakon, P. 2007: A concurrence of light and heavy chain deposition disease and diabetic nephropathy Journal of the Medical Association of Thailand 90(10): 2204-2208
Roda, L.; David, M.J.; Souche, S.; Coiffier, B.; Creyssel, R. 1985: Gamma 3 heavy chain disease and monoclonal IgMk in a patient with a gastrointestinal lymphoma Haematologica 70(2): 115-119
Kyle, R.A.; Greipp, P.R.; Banks, P.M. 1981: The diverse picture of gamma heavy-chain disease. Report of seven cases and review of literature Mayo Clinic Proceedings 56(7): 439-451